Patents Assigned to NovoBiotic Pharmaceuticals LLC
  • Patent number: 11891415
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: February 6, 2024
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Patent number: 11851458
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: October 13, 2021
    Date of Patent: December 26, 2023
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 11203616
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of the novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: December 21, 2021
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Dallas Hughes, Amy Spoering, Aaron J. Peoples, Losee Lucy Ling, Anthony Nitti, William Millett, Ashley Zullo, Kim Lewis, Slava Epstein, Alysha Desrosiers, Catherine Achorn, Kelly Demeo
  • Patent number: 11174290
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: November 16, 2021
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 10414800
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: September 17, 2019
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 9402878
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: August 2, 2016
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Patent number: 9163065
    Abstract: The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: October 20, 2015
    Assignee: NovoBiotic Pharmaceuticals, LLC
    Inventors: Aaron J. Peoples, Dallas Hughes, Losee Lucy Ling, William Millett, Anthony Nitti, Amy Spoering, Victoria Alexandra Steadman, Jean-Yves Christophe Chiva, Linos Lazarides, Michael Kenyon Jones, Karine Gaelle Poullennec, Kim Lewis, Slava Epstein
  • Publication number: 20120302613
    Abstract: The invention relates generally to novel antibiotics and their analogs, to processes for the preparation of these novel antibiotics, to pharmaceutical compositions comprising the novel antibiotics; and to methods of using the novel antibiotics to treat or inhibit various disorders.
    Type: Application
    Filed: May 24, 2012
    Publication date: November 29, 2012
    Applicant: NOVOBIOTIC PHARMACEUTICALS LLC
    Inventors: Aaron PEOPLES, Losee Lucy LING, Kim LEWIS, Slava S. EPSTEIN
  • Publication number: 20110136752
    Abstract: The invention relates generally to novel antibiotics and their analogs, to processes for the preparation of these novel antibiotics, to pharmaceutical compositions comprising the novel antibiotics; and to methods of using the novel antibiotics to treat or inhibit various disorders.
    Type: Application
    Filed: December 6, 2010
    Publication date: June 9, 2011
    Applicant: NOVOBIOTIC PHARMACEUTICALS LLC
    Inventors: Aaron PEOPLES, Lucy Losee LING, Kim LEWIS, Zhizhen ZHANG
  • Publication number: 20090156514
    Abstract: The invention relates generally to novel macrolactams and their analogs, to processes for the preparation of these novel macrolactams, to pharmaceutical compositions comprising the novel macrolactams; and to methods of using the novel macrolactams to treat or inhibit various disorders.
    Type: Application
    Filed: August 22, 2008
    Publication date: June 18, 2009
    Applicant: NovoBiotic Pharmaceuticals LLC
    Inventors: Aaron PEOPLES, Qibo ZHANG, Charles MOORE, Losee Lucy LING, Mithra ROTHFEDER, Kim Lewis